Cell No. : Cell Name
RCB3010 : RPMI8226
update : 2023/10/16
|
Comment | Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.). |
Comment from the depositor | |
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Fukuda, Hiroshi
|
Originator |
Benda et al.
|
Year of deposit |
2010
|
Original cell |
TKG0243
|
Animal |
_human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Tissue |
bone marrow
|
Disease name |
myeloma
|
Classification |
cancer
|
History |
Cell Resource Center for Biomedical Research, Tohoku University(TKG0243)
|
|
Lifespan |
infinite
|
Morphology |
lymphocyte-like
|
Cellosaurus(Expasy) |
CVCL_0014
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent/Suspension cells
|
Culture medium |
|
RPMI1640 + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
dilution, pipetting
|
Culture information
|
Passage ratio |
|
1 : 5 split
|
SC frequency |
|
Subculture : 2 times/week
|
Temperature |
|
37
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Acholeplasma |
|
(-)
|
Animal PCR |
|
OK
|
Virus (HIV) |
|
(-)
|
Virus (HTLV-1) |
|
(-)
|
STR(human) |
|
OK
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
2
|
User's Publication |
8
|
User's Publication |
19629
Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution
Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution
Int J Mol Sci
2023
24(24):17486
PubMed ID: 38139315
DOI: 10.3390/ijms242417486
|
12010
Teratake Y, Takashina T, Iijima K, Sakuma T, Yamamoto T, Ishizaka Y.
Development of a protein-based system for transient epigenetic repression of immune checkpoint molecule and enhancement of antitumour activity of natural killer cells.
Br. J. Cancer
2020
PubMed ID: 31959920
DOI: 10.1038/s41416-019-0708-y
|
4270
Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, Kito N, Nozaki Y, Saito M, Iwamura H, Kanakura Y.
Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway.
Leuk. Lymphoma
2018
PubMed ID: 28730859
DOI: 10.1080/10428194.2017.1339878
|
4500
Tanaka M, Zhu Y, Shionyu M, Ota N, Shibata N, Watanabe C, Mizusawa A, Sasaki R, Mizukami T, Shiina I, Hasegawa M.
Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death.
Eur J Med Chem
2018
146:636-650
PubMed ID: 29407987
DOI: 10.1016/j.ejmech.2018.01.045
|
15045
Tsubaki M, Takeda T, Tomonari Y, Mashimo K, Koumoto YI, Hoshida S, Itoh T, Imano M, Satou T, Sakaguchi K, Nishida S.
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs
J Cell Physiol
2018
233(5):4258-4271.
PubMed ID: 29057477
DOI: 10.1002/jcp.26245
|
14622
Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y.
Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells
Oncotarget
2017
8(28):45928-45942
PubMed ID: 28521284
DOI: 10.18632/oncotarget.17498
|
12516
Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J.
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin
Oncotarget
2016
7(25):38586-38597
PubMed ID: 27233074
DOI: 10.18632/oncotarget.9558
|
14309
Ninomiya S, Kawano M, Abe T, Ishikawa T, Takahashi M, Tamura M, Takahashi Y, Nashimoto M.
Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines
PLoS One
2015
10(3):e0118631
PubMed ID: 25730316
DOI: 10.1371/journal.pone.0118631
|